» Articles » PMID: 31014137

Asthma Prevalence Among Women Aged 18 to 44 in the United States: National Health and Nutrition Examination Survey 2001-2016

Overview
Journal J Asthma
Publisher Informa Healthcare
Date 2019 Apr 25
PMID 31014137
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

To provide updated prevalence estimates of asthma and asthma medication use for women of childbearing age in the United States. Using data from 11,383 women aged 18-44, including a subset of 1,245 pregnant women, enrolled in the National Health and Nutrition Examination Survey (2001-2016), we assessed the age-adjusted prevalence of self-reported diagnosed asthma. For women aged 18-44, we stratified by year, demographics, and other characteristics. Furthermore, we assessed asthma medication use among women aged 18-44 with asthma. After age-adjustment, 9.9% (95% confidence interval (CI) 9.2%, 10.7%) of women aged 18-44 and 10.9% (95% CI 7.2%, 14.6%) of pregnant women reported having asthma. Asthma prevalence was highest in 2015-2016 (12.0% 95% CI 9.8%, 14.3%) and lowest in 2003-2004 (8.6% 95% CI 6.4%, 10.8%). Women aged 18-44 with Medicaid or State Children's Health Insurance Program insurance coverage (16.8% 95% CI 14.5%, 19.2%), obesity (14.4% 95% CI 12.9%, 15.8%), diabetes (18.7% 95% CI 12.1%, 25.2%), hypertension (16.6% 95% CI 14.2%, 19.0%), and current smokers (12.8% 95% CI 11.4%, 14.2%) had the highest asthma prevalence. Of women with asthma, 38.3% (95% CI 34.5%, 42.1%) reported using asthma medications in the past 30 days. Among women of childbearing ages, asthma burden varies across demographic and clinical characteristics and has increased in recent years.

Citing Articles

Factors affecting asthma control in pregnancy: A cross-sectional study.

Toori K, Qureshi M Pak J Med Sci. 2024; 40(6):1146-1150.

PMID: 38952503 PMC: 11190417. DOI: 10.12669/pjms.40.6.8659.


Asthma prevalence among United States population insights from NHANES data analysis.

Swed S, Sawaf B, Al-Obeidat F, Hafez W, Rakab A, Alibrahim H Sci Rep. 2024; 14(1):8059.

PMID: 38580691 PMC: 10997649. DOI: 10.1038/s41598-024-58429-5.


Challenges in the successful management of asthma during conception, pregnancy and delivery.

Gade E, Tidemandsen C, Hansen A, Ulrik C, Backer V Breathe (Sheff). 2022; 18(2):220013.

PMID: 36337135 PMC: 9584572. DOI: 10.1183/20734735.0013-2022.


Impact of the COVID-19 Pandemic on Obstetric Interventions at a Public Hospital.

Johnson T, Jamieson D, Geary F, Stanhope K, Boulet S Womens Health Issues. 2022; 33(1):10-16.

PMID: 36117075 PMC: 9381428. DOI: 10.1016/j.whi.2022.08.003.


Anxiety, depression, and asthma: New perspectives and approaches for psychoneuroimmunology research.

Caulfield J Brain Behav Immun Health. 2021; 18:100360.

PMID: 34661176 PMC: 8502834. DOI: 10.1016/j.bbih.2021.100360.


References
1.
Kwon H, Triche E, Belanger K, Bracken M . The epidemiology of asthma during pregnancy: prevalence, diagnosis, and symptoms. Immunol Allergy Clin North Am. 2006; 26(1):29-62. DOI: 10.1016/j.iac.2005.11.002. View

2.
Enriquez R, Griffin M, Carroll K, Wu P, Cooper W, Gebretsadik T . Effect of maternal asthma and asthma control on pregnancy and perinatal outcomes. J Allergy Clin Immunol. 2007; 120(3):625-30. DOI: 10.1016/j.jaci.2007.05.044. View

3.
Max W, Sung H, Shi Y . Who is exposed to secondhand smoke? Self-reported and serum cotinine measured exposure in the U.S., 1999-2006. Int J Environ Res Public Health. 2009; 6(5):1633-48. PMC: 2697933. DOI: 10.3390/ijerph6051633. View

4.
Finer L, Zolna M . Declines in Unintended Pregnancy in the United States, 2008-2011. N Engl J Med. 2016; 374(9):843-52. PMC: 4861155. DOI: 10.1056/NEJMsa1506575. View

5.
Hansen C, Joski P, Freiman H, Andrade S, Toh S, Dublin S . Medication exposure in pregnancy risk evaluation program: the prevalence of asthma medication use during pregnancy. Matern Child Health J. 2012; 17(9):1611-21. PMC: 3797257. DOI: 10.1007/s10995-012-1173-x. View